Search

Author/Creator Vande Casteele, N

1. DOP45 Adequate infliximab exposure during the induction phase is associated with early complete fistula response in patients with fistulizing Crohn's disease: a post-hoc analysis of the ACCENT-2 trial. (25th January 2019)

Authors:
Vande Casteele, N; Papamichael, K; Jeyarajah, J; Osterman, M T; Cheifetz, A S
Journal:
Journal of Crohn's and colitis
Issue:
Volume 13(2019)Supplement 1
Page Start:
S053
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. P246 The association of serum 7α-hydroxy-4-cholesten-3-one (7C4) with Bile Acid Diarrhoea in patients with inflammatory bowel disease. (16th January 2018)

Authors:
Battat, R; Duijvestein, M; Vande Casteele, N; Singh, S; Renshaw, M; McFarland, J; Chen, H; Jain, A; Sandborn, W J; Boland, B S
Journal:
Journal of Crohn's and colitis
Issue:
Volume 12:Number 1(2018:Jan.)Supplement 1
Page Start:
S224
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. P306 MORF-057, an oral selective α4β7 integrin inhibitor for Inflammatory Bowel Disease, leads to specific target engagement in a single and multiple ascending dose study in healthy subjects. (27th May 2021)

Authors:
Ray, A; Cui, D; Lee, D; Mangada, M M; Jones, J; Bain, G; Traber, P G; Vrishabhendra, L H; Krzeski, P W; Vande Casteele, N; Reardon, M M; Stern, T P; Soo, C L; Nguyen, H; Rogers, B N; Linde, P G
Journal:
Journal of Crohn's and colitis
Issue:
Volume 15(2021)Supplement 1
Page Start:
S333
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. P479 Reliability and responsiveness of histologic disease activity indices in Crohn's Disease. (30th January 2023)

Authors:
Solitano, V; Schaeffer, D F; Hogan, M; Pai, R K; Zou, G; Pai, R K; Vande Casteele, N; Parker, C E; Remillard, J; Christensen, B; Panaccione, R; Sands, B E; D'Haens, G; Feagan, B G; Ma, C; Jairath, V
Journal:
Journal of Crohn's and colitis
Issue:
Volume 17(2023)Supplement 1
Page Start:
i608
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. P631 Development and validation of a clinical scoring tool for predicting treatment outcomes with vedolizumab in patients with ulcerative colitis. (25th January 2019)

Authors:
Dulai, P S; Singh, S; Vande Casteele, N; Meserve, J; Winters, A; Chablaney, S; Aniwan, S; Shashi, P; Kochhar, G; Weiss, A; Koliani-Pace, J L; Gao, Y; Boland, B S; Chang, J T; Faleck, D; Hirten, R; Ungaro, R; Lukin, D; Sultan, K; Hudesman, D
Journal:
Journal of Crohn's and colitis
Issue:
Volume 13(2019)Supplement 1
Page Start:
S433
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗